Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.

Serum 25-hydroxyvitamin D (25-OH-D) and 1,25-dihydroxyvitamin D (1,25-(OH)2D) and bone mineral content by the photon-absorption technique were determined in eight patients with X-linked hypophosphatemic rickets treated for at least 24 months with oral sodium phosphate and high-dosage ergocalciferol (vitamin D2). Mean 25-OH-D2 level was 129.5 +/- 67.5 ng/mL (mean +/- SD); the level of 25-OH-D3 was 10.5 +/- 5.8 ng/mL. These values were significantly higher than in normal subjects (total 25-OH-D mean of 27 +/- 10 ng/mL). Serum 1,25-(OH)2D was 16.9 +/- 8.5 pg/mL (mean +/- SD) in the eight patients, significantly lower than 47 +/- 16 pg/mL in 27 age-matched controls. Values indicative of significant demineralization were found in seven of the eight phsophate-treated patients, who had no radiologic evidence of rickets. These results suggest that any theory of the pathogenesis of this disorder must account for inappropriate renal vitamin D metabolism and for renal hyperphosphaturia. The failure of high-dosage oral phosphate and ergocalciferol to fully correct demineralization may suggest a role for calcitriol (1,25-(OH)2D3) as a therapeutic agent.

[1]  H. DeLuca.  Recent advances in our understanding of the vitamin D endocrine system. , 1979, Journal of steroid biochemistry.

[2]  H. DeLuca,et al.  The determination of 24,25-dihydroxyvitamin D and 25,26-dihydroxyvitamin D in plasma from normal and nephrectomized man. , 1979, The Journal of laboratory and clinical medicine.

[3]  H. DeLuca,et al.  Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. , 1978, The New England journal of medicine.

[4]  R. Mazess,et al.  Effect of prednisone on growth and bone mineral content in childhood glomerular disease. , 1978, American journal of diseases of children.

[5]  H. DeLuca,et al.  Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid. , 1978, Pediatrics.

[6]  R. Mazess,et al.  Bone mineral status measured by direct photon absorptiometry in childhood renal disease. , 1977, Pediatrics.

[7]  H. DeLuca,et al.  Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. , 1977, Analytical biochemistry.

[8]  J. Walton,et al.  Familial Hypophosphatemic Rickets , 1976, Clinical pediatrics.

[9]  C. Scriver,et al.  Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency. , 1976, The American journal of clinical nutrition.

[10]  H. DeLuca,et al.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. , 1976, Archives of biochemistry and biophysics.

[11]  J. Wergedal,et al.  Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat , 1975, Science.

[12]  C. Scriver.  Rickets and the pathogenesis of impaired tubular transport of phosphate and other solutes. , 1974, The American journal of medicine.

[13]  F. Glorieux,et al.  Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. , 1972, The New England journal of medicine.

[14]  J. Lewy,et al.  Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets. , 1972, The Journal of pediatrics.

[15]  F. N. Silverman,et al.  Acceleration of growth with combined vitamin D-phosphate therapy of hypophosphatemic resistant rickets. , 1972, The Journal of pediatrics.

[16]  M. Garabédian,et al.  25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets. , 1972, The Journal of clinical investigation.

[17]  F. Glorieux,et al.  Serum Parathyroid Hormone in X-Linked Hypophosphatemia , 1971, Science.

[18]  H. C. Harrison,et al.  Growth disturbance in hereditary hypophosphatemia. , 1966, American journal of diseases of children.

[19]  F. Albright,et al.  Rickets resistant to vitamin D therapy. , 1937 .

[20]  M. Haussler,et al.  Serum 1,25-dihydroxyvitamin D in bone diseases. , 1979, The New England journal of medicine.

[21]  F. Glorieux,et al.  Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR). , 1978, Advances in experimental medicine and biology.

[22]  M. Haussler,et al.  Influence of phosphate depletion on the biosynthesis and circulating level of 1alpha,25-dihydroxyvitamin D. , 1977, Advances in experimental medicine and biology.

[23]  R B Mazess,et al.  Estimation of bone and skeletal weight by direct photon absorptiometry. , 1971, Investigative radiology.